). The Inoue balloon was designed so that adjusting injection volume would change the diameter of the balloon. The upper limit of the balloon diameter is chosen according to the patient's body weight (26-mm dilating diameter for patients c50 kg, 28-mm dilating diameter for patients 50-60 kg, and 30-mm dilating diameter for patients >60 kg). Inflation is started at less than the predetermined upper-limit diameter. If the hemodynamic results are suboptimal, the procedure is repeated by increasing the balloon diameter to the predetermined level. If optimal hemodynamic results are not obtained at the balloon's maximum diameter, additional inflation is not attempted as a general rule.
After administration of local anesthesia, right heart catheterization was performed through the right femoral vein. Right atriography was performed to determine the septal puncture site for the Brockenbrough needle. One patient requiring emergency operation could not undergo Doppler echocardiography after percutaneous transvenous mitral commissurotomy. The Toshiba SSH 65A system was used for this study. Mitral ejection fraction slope, mitral valve excursion, left atrial diameter, and mitral valve area by the pressure half-time method5 were determined. The presence and severity of mitral regurgitation was assessed by pulsed Doppler and real-time two-dimensional flow imaging system before and after percutaneous transvenous mitral commissurotomy. The severity of the mitral regurgitation was graded as none, mild, moderate, or severe based on the extension of the regurgitant jet in the left atrium. In addition, Doppler echocardiography was used to assess the atrial septal defect after percutaneous transvenous mitral commissurotomy.
Based on the characteristics of the anatomic structures of the mitral valve according to echocardiography, primarily the leaflets and secondarily the subvalvular apparatus, patients were divided into three groups ( Figure 2 
Clinical Follow-up
With the exception of a few patients living far from the hospital who were followed up by telephone interview, most patients were followed up in our department with two-dimensional and Doppler echocardiographic assessment.
Data and Statistical Analysis
Two-dimensional and Doppler echocardiographic recordings were analyzed by experienced echocardiographers who were unaware of the hemodynamic results. To determine the reproducibility of the echocardiographic assessment, 106 randomly selected echocardiograms were independently reviewed by two observers. Interobserver discordance between two observers for echocardiographic subgrouping was six of 106 patients (6%).
Mean and standard deviations were determined for all hemodynamic variables and for calculated mitral valve areas. Student's t test and x2 test were used for comparing hemodynamic parameters and clinical results. Multiple linear regression analysis was used to identify the predictive factors for symptomatic improvement after the procedure, mitral valve area after the procedure, incidence of mitral regurgitation after the procedure, symptomatic status during the follow-up period, and mitral valve area during the follow-up period. The examined factors were age, sex, cardiac rhythm, history of commissurotomy, echocardiographic subgrouping, mitral valve area before and after the procedure, mean mitral pressure gradient before and after the procedure, mean left atrial pressure before and after the procedure, balloon diameter normalized to body surface area, symptomatic improvement after the procedure, and new mitral regurgitation according to left ventriculography. A probability value less than 0.05 was considered significant.
Results

Clinical and Hemodynamic Improvement
The balloon could be dilated as planned in 104 of 106 patients (98%). Significant symptomatic improvement defined as reclassification by one or more New York Heart Association (NYHA) functional Classes was achieved in 97 of 106 patients (92%, from NYHA Class IV to I in two patients, from III to I in nine patients, from II to I in 64 patients, from IV to IL in two patients, and from III to II in 20 patients). The resting hemodynamic variables are shown in Figure 3 Figure 6 ). (Figure 7 ). In addition, fusion of the subvalvular apparatus to the posterior ventricular wall was evident. (Figure 7) .
The third patient was a 55-year-old woman of group 3. Echocardiography revealed a rigid valve with severe subvalvular involvement but was limited to the chordae tendinae. Percutaneous transvenous mitral commissurotomy was performed with a 28.5-mm dilating balloon. Left atrial pressure increased from 24 to 26 mm Hg after dilatation. Left ventriculography revealed Seller's 3+ mitral regurgitation after the procedure. Although the patient's hemodynamics remained stable, elective surgery was performed 29 days later because of suboptimal clinical results. Tearing of the anterolateral commissure and avulsion of the anterolateral papillary muscle were present (Figure 7) .
The final patient was a 42-year-old woman of group 1. Echocardiographic findings were consistent with a pliable valve. Percutaneous transvenous mitral commissurotomy was performed with a 28-mm diameter dilating balloon. Immediately after the procedure, the mean left atrial pressure fell from 20 to 18 mm Hg, but new mild mitral regurgitation was found by Doppler echocardiography. Because her condition was relatively good after the procedure, she was followed medically as an outpatient. However, her symptoms worsened gradually, and elective surgery had to be performed 9 months later. Tearing of the posterior mitral leaflet was present (Figure 7) .
Discussion
In earlier studies, percutaneous balloon commissurotomy was used in patients with noncalcified mitral valves.6 More recently, McKay et a17 reported the efficacy of balloon commissurotomy even in calcific disease. Our study showed that percutaneous transvenous mitral commissurotomy could induce clinical and hemodynamic improvement without major complications in patients with pliable mitral stenosis. Improvement in valvular function was documented by decreases in left atrial pressure, mitral pressure gradient, and pulmonary artery pressure during exercise as well as by the increase zt CA in cardiac index. However, patients with rigid valves might show minimal clinical improvement, and in some patients, mitral valve replacement within a few days to weeks of the procedure was required.
Earlier pathologic studies showed that the most important component in mitral stenosis was Mitral regurgitation is an important complication to be kept in mind because production of mitral regurgitation after surgery was reported to be associated with poor prognosis.9 In patients undergoing surgery, production of significant mitral regurgitation was reported to be associated with a tear of the leaflets or rupture cf the chordae tendinae.10 In fact, our operative findings in patients requiring valve replacement for severe mitral regurgitation were similar to those previous findings. Production of mitral regurgitation was less frequent in patients with pliable valve, and when it occurred, the severity was mild and clinically insignificant in all but one patient. In patients with semipliable or rigid valves, the incidence and severity of significant mitral regurgitation increased, and three patients in these groups required surgery. Morrow et all' reported that in 11 of 12 patients with completely mobile valve leaflets, the left atrial pressure returned to normal after closed mitral commissurotomy, but in six of seven patients with totally immobile valves, the left atrial pressure remained high because of significant residual stenosis or mitral regurgitation induced at operation. These results of closed commissurotomy predicted that commissural separation would be the more common response to balloon mitral commissurotomy. This may be the case in patients with pliable valves. In patients with more rigid valves, however, splitting of the commissures did not occur consistently. Inadvertent tearing of valve leaflets or disruption of the valve ring and chordae tendinae may lead to production of significant mitral regurgitation. Multiple linear regression analysis identified echocardiographic subgrouping as the significant predictor for symptomatic improvement, mitral valve area, and new or deterioration of preexisting mitral regurgitation immediately after balloon commissurotomy. Thus, in patients with pliable leaflets, with no or low-grade calcification of the leaflets, and with no severe subvalvular lesions, significant symptomatic improvement is anticipated by restoration of sufficient mitral valve area without the concurrence of significant mitral regurgitation.
Palacios et a112 reported that there was one death (3%) and one thromboembolic episode (3%) after valvuloplasty. McKay13 also reported one death (2%) and two embolic cerebrovascular accidents (3%) in a large series involving 63 patients. We had no deaths nor thromboembolic accidents in our 106 patients. Because fatalities in the studies of Palacios et al and McKay occurred in severely ill patients, we cannot make simple comparisons with our results. We speculate that our results are related to the nature of the Inoue balloon, especially its flowdirected passage from the left atrium to the left ventricle. Left-to-right shunt after valvuloplasty was reported in 11% of patients by Palacios et al and in 21% by McKay, but it was hemodynamically insignificant in all patients. In our series, five patients (5%) had evidence of interatrial shunting, but it was insignificant in all. We ascribe this low incidence of defect creation to the low profile of the Inoue balloon and to the stretching and thinning of the balloon portion attainable by reinsertion of the stiffening cannula before pulling the balloon out across the septum. Subcutaneous hematoma from the right femoral vein occurred in seven patients (7%), of whom two required subsequent blood transfusion. Although we have no experience with the double balloon, the reported incidence of mitral regurgitation is apparently higher than the incidence in our series with the Inoue single balloon, and this incidence may suggest the greater propensity of double balloons to produce mitral regurgitation.
In our 9 months of follow-up, six patients (6%) had recurrent symptoms, and the calculated mitral valve area by pressure half-time method revealed restenosis after a successful initial percutaneous transvenous mitral commissurotomy. This recurrence was particularly prevalent in patients of group 3, 50% of whom had recurrence of symptoms, which was a significantly higher incidence than in the other two groups with more pliable valves. Multiple linear regression analysis identified the preprocedural echocardiographic subgrouping as the significant preUictor for sustained symptomatic improvement and mitral valve area during followup. Thus, patients with pliable, noncalcified valves without severe subvalvular lesion will have predictably good results after commissurotomy. Abascal et al'4 reported that assessments of valvular morphology by two-dimensional echocardiography may be useful for identifying patients with restenosis. In their series, 20 patients were followed up by echocardiography, which revealed that four patients had valvular restenosis defined as more than 25% reduction in the mitral valve area at follow-up. Echocardiographic score of valvular morphology was significantly higher (with increasing abnormality) in patients with restenosis, and this score was the significant predictor of percent decrease in valve area. Surgical reports have also stressed that the most important factor influencing long-term results was mitral valve calcification.'5 Although the precise mechanism of restenosis remains unclear in our study, surgical reports suggest that restenosis is the result of the inexorable progress of the fibrotic process, namely deposits of calcium and scarring of the valves.16"17 If parallels can be drawn to surgical commissurotomy, the same mechanism may be the modus operandi in restenosis after transvenous valve commissurotomy.
In clinical practice, recognizing the clearly favorable and unfavorable types of valves is usually not difficult. From be mentioned, however, that the incidence of mitral regurgitation was 20%, and in two patients, surgery was required after percutaneous transvenous mitral commissurotomy. Although these results were less optimal than those in patients with pliable valves, most patients showed excellent results after percutaneous transvenous mitral commissurotomy. Moreover, the procedure is performed with local anesthesia without the need of a thoracotomy. If stenosis persists or recurs after percutaneous transvenous mitral commissurotomy, the procedure can be repeated, or if needed, cardiac surgery can still be performed for the first time, which is distinctly easier to perform than repeated cardiac surgery.
Conclusion
The present study shows that percutaneous transvenous mitral commissurotomy achieves immediate hemodynamic and clinical improvement in patients with a pliable valve but not in patients with a rigid valve. We conclude that the most important factors determining the hemodynamic and clinical outcome after percutaneous transvenous mitral commissurotomy are the anatomic and pathologic features of the mitral apparatus. Follow-up studies will be needed to assess the long-term efficacy of the procedure, but results comparable at least to closed commissurotomy might be anticipated.
